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Abstract
The life sciences can benefit greatly from imaging technologies that connect microscopic 
discoveries with macroscopic observations. Photoacoustic tomography (PAT), a highly sensitive 
modality for imaging rich optical absorption contrast over a wide range of spatial scales at high 
speed, is uniquely positioned for this need. In PAT, endogenous contrast reveals tissue’s 
anatomical, functional, metabolic, and histologic properties, and exogenous contrast provides 
molecular and cellular specificity. The spatial scale of PAT covers organelles, cells, tissues, organs, 
and small-animal organisms. Consequently, PAT is complementary to other imaging modalities in 
contrast mechanism, penetration, spatial resolution, and temporal resolution. We review the 
fundamentals of PAT and provide practical guidelines to the broad life science community for 
matching PAT systems with research needs. We also summarize the most promising biomedical 
applications of PAT, discuss related challenges, and envision its potential to lead to further 
breakthroughs.
INTRODUCTION
By providing a comprehensive illustration of life from molecular to anatomical aspects, 
modern biomedical imaging has revolutionized the life sciences. Imaging technologies have 
been used through history to peer into complex biological systems in ever-more informative 
ways: finer spatial resolution, richer contrast, higher imaging speed, deeper penetration, and 
greater detection sensitivity. At the macroscopic scale, a number of methods including 
magnetic resonance imaging, X-ray computed tomography, and ultrasound imaging have 
excellent penetration for anatomical imaging. Positron emission tomography and single-
photon emission computed tomography have deep penetration and excellent sensitivity to 
radioactively-labeled molecular probes. At the microscopic scale, optical microscopy can 
detail biological phenomena with subcellular and suborganelle resolutions at superficial 
depths. However, the different imaging contrast mechanisms of these imaging tools and their 
different length scales have hindered correlative multiscale studies of biological problems. It 
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is imperative to build a continuum from microscopic to macroscopic imaging in the life 
sciences.
In the last decade, photoacoustic tomography (PAT, also referred to as optoacoustic or 
thermoacoustic tomography) has proven capable of multiscale imaging with a consistent 
contrast mechanism; thus, it is well situated to bridge the microscopic and macroscopic 
domains in the life sciences. PAT is a hybrid imaging modality that acoustically detects 
optical absorption contrast via the photoacoustic (PA) effect, a physical phenomenon that 
converts absorbed optical energy into acoustic energy 1. The combination of optical 
excitation with ultrasonic detection offers three advantages: (1) PAT is inherently suited for 
functional, metabolic, and histologic imaging through endogenous contrast, and for 
molecular and cellular imaging through exogenous contrast. (2) Because biological tissue is 
orders of magnitude more transparent to sound than to light, in terms of scattering mean free 
path, PAT provides far greater penetration with a scalable spatial resolution than optical 
microscopy. (3) PAT is complementary to and compatible with other imaging modalities, 
especially optical imaging and ultrasound imaging.
It took more than a century for photoacoustics to evolve from a known physical phenomenon 
to a valuable biomedical imaging modality. Although the PA effect was first reported by Bell 
in 1880 with the invention of the photophone 1, one hundred years passed before Bowen 
proposed to use this phenomenon for imaging, by excitation using ionizing radiation (e.g., 
high-energy electrons and X-ray photons) or non-ionizing radiation (e.g., radiowaves and 
microwaves) 2. He showed radiowave-induced one-dimensional (1D) depth-resolved 
imaging without intended lateral resolution, but did not mention the possibility of optical 
excitation in his patent. In the 1990s, the laser-induced counterpart of 1D depth-resolved 
imaging was demonstrated 3–7. With inverse reconstruction or spherically focused ultrasonic 
detection, 2D 8 and 3D 9, 10 PAT, with both lateral and axial resolutions, were finally 
developed. In the decade that followed, several milestones were reached in anatomical, 
functional, and molecular PAT11–15. Particularly, the first functional photoacoustic computed 
tomography (PACT) 11 as well as the first functional photoacoustic microscopy (PAM) 12 
heralded the fast growth of the field thereafter.
Although turn-key commercial PAT systems are now available for preclinical applications, 
users can still benefit from understanding the principles and characteristics of PAT, 
especially when choosing or optimizing a PAT system for a specific application. In this 
review, we introduce the basic principles of PAT and emphasize its functional and molecular 
imaging capabilities in the preclinical life sciences. We provide practical guidelines with 
case studies to scientists who want to choose or develop a PAT system that can best serve 
their research, and we summarize the most exciting biomedical applications. We also discuss 
the current technical challenges of PAT, which point to further potential breakthroughs.
PRINCIPLES OF PAT
Although PAT has been tailored for diverse applications, its principles remain the same. The 
imaging process typically starts with a short laser pulse fired at biological tissue. As photons 
propagate into the tissue, some are absorbed by biomolecules (e.g., hemoglobin, DNA/RNA, 
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lipids, water, melanin, and cytochrome). The various absorption mechanisms in PAT include 
(but are not limited to) electronic absorption, vibrational absorption 16, stimulated Raman 
absorption 17, and surface plasmon resonance absorption 18. The absorbed optical energy is 
usually partially or completely converted into heat through nonradiative relaxation of excited 
molecules (Fig. 1a). The heat-induced pressure wave propagates in tissue as an ultrasound 
wave. The ultrasound wave is detected outside the tissue by an ultrasonic transducer or 
transducer array to form an image that maps the original optical energy deposition inside the 
tissue (Fig. 1b). PAT has a 100% relative sensitivity to small optical absorption variations, 
which means a given percentage change in the optical absorption coefficient yields the same 
percentage change in the PA signal amplitude. By contrast, back-scattering-based confocal 
microscopy has a relative sensitivity to optical absorption in blood of only ~6% at 560 nm 
and ~0.08% at 800 nm. Because PAT does not rely on fluorescence, which usually has a 
quantum yield less than 100%, it can image nearly all molecules 15, 19, 20.
Major PAT implementations
The major components of a typical PAT system include a short-pulsed laser (e.g., a 
nanosecond Q-switched Nd:YAG laser) for efficient wideband PA signal generation (Box 1), 
a wideband ultrasonic transducer or transducer array for signal detection, a data acquisition 
system for signal amplification and digitization, and a computer for system synchronization, 
data collection, and image formation. The bandwidth of the transducer should match the 
bandwidth of the PA signals that originate from small optical absorbers at the desired depth 
and survive the frequency-dependent acoustic attenuation of tissue. Matched broadband 
detection optimizes signal-to-noise ratio, and thus detection sensitivity and axial resolution.
Box 1
Light sources in PAT
PAM and PACT have different requirements for optimal pulsed lasers, mainly in their 
pulse repetition rate, pulse energy, pulse width, and wavelength tunability. In general, 
while a high pulse repetition rate is key to PAM, a high pulse energy output is important 
to PACT.
For raster-scanning PAM (Fig. 2a–c), the laser pulse repetition rate should be more than 1 
kHz for rapid 3D imaging. For example, to raster scan 200 × 200 points within 0.1 s, the 
pulse repetition rate must be at least 400 kHz. For PACT (Fig. 2d–g), where a single 
pulse can generate a 2D or 3D image, a pulse repetition rate of tens of hertz is usually 
sufficient. With a relatively small optical excitation region, PAM usually employs less 
pulse energy (<1 μJ for OR-PAM and <1 mJ for AR-PAM) than PACT (>10 mJ). For 
both PAM and PACT, the laser pulse width should be less than the acoustic transit time 
across the targeted axial resolution length (on the scale of nanoseconds). Finally, the laser 
wavelength should be tunable for spectroscopic functional and molecular PAT, where 
multiple PA images are acquired at different wavelengths. Q-switched Nd:YAG pumped 
OPO, Ti:Sapphire and dye laser systems are most commonly used as they provide 
sufficient pulse energies with nanosecond pulse widths at biologically relevant 
wavelengths. Unfortunately, the pulsed laser sources are generally bulky and expensive. 
Recently, pulsed laser diodes 102 and light emitting diodes 103 have been reported as 
Wang and Yao Page 3
Nat Methods. Author manuscript; available in PMC 2016 August 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
compact and less expensive alternatives; however, they have low pulse energies even 
when used in group (e.g., stacking multiple laser diodes), resulting in low signal-to-noise 
ratio. Employing temporally coded excitation (e.g., Golay codes 103) improves signal-to-
noise ratio at the cost of imaging speed.
PAT has been implemented with two major image formation methods (Fig. 2). The first 
method, focused-scanning image formation, commonly used in PAM, is based on 
mechanical scanning of a focused excitation light beam and a focused single-element 
ultrasonic transducer (Fig. 2a–c). The second method, used in PACT, is inverse 
reconstruction image formation, based on wide-field light illumination and acoustic 
detection at multiple locations (Fig. 2d–g). PAT can also be implemented for 
endoscopy 21–24. Due to the high scalability of PAT, the imaging performances of different 
implementations are highly overlapping, with convenient transitions among them. In 
addition, complementary original implementations can be hybridized in various forms. 
Furthermore, combining optical excitation with acoustic detection, PAT is compatible with 
complementary imaging modalities, especially optical imaging and ultrasound imaging 25.
PAM can be further classified into optical-resolution PAM (OR-PAM) (Fig. 2a–b), where the 
optical focus is much tighter than the acoustic focus, and acoustic-resolution PAM (AR-
PAM) (Fig. 2c), where the acoustic focus is tighter than the diffused optical beam. In both 
cases, the axial resolution is determined acoustically. In OR-PAM, the optically-determined 
lateral resolution is typically much finer than the axial resolution. The optical focusing can 
be either strong or weak, depending on the desired spatial resolution and penetration. 
Conversely, in AR-PAM, the axial resolution is typically finer than the lateral resolution.
PACT can be configured with a 1D ultrasonic transducer array 26, 27 (Fig. 2d–e), a 2D 
transducer array (Fig. 2f) 28, 29, or their scanning equivalents (Fig. 2g) 11, 30, 31. For 1D-
array based PACT, the axial (or radial) and lateral (or tangential) resolutions in the imaging 
plane, derived from reconstruction, are typically finer than the elevational resolution, 
determined by cylindrical acoustic focusing. In the imaging plane, the axial (or radial) 
direction is along the axis that perpendicularly passes the transducer element surface through 
the center (i.e., along the acoustic axis), and the lateral (or tangential) direction is 
perpendicular to the axial (or radial) direction. The elevational direction is orthogonal to the 
imaging plane. For 2D-array based PACT, the resolutions can be nearly isotropic at the 
center of the field of view. Compared with PAM, state-of-the-art PACT generally has higher 
imaging speeds and greater penetration, but lower spatial resolutions.
Image formation in PAT
Simply speaking, with a known speed of sound, PAT forms images by numerically reversing 
the received PA signals in time back to their original positions in space. In PAM (Fig. 2a–c), 
each PA signal is received primarily from the volume laterally confined by the optical focus 
or acoustic focus, whichever is smaller; it is converted into a 1D image of the optical energy 
deposition along the acoustic axis by extracting its envelope—the amplitude modulation 
curve of the radio-frequency PA signal. In PACT (Fig. 2d–g), each ultrasonic transducer 
element receives PA signals over a large acceptance angle, and data from all transducer 
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elements are used to reconstruct an image using the inverse spherical Radon transformation, 
which is approximately similar to triangulation used in the Global Positioning System 32, 33.
Depending on the image formation method, PAT may require mechanical or electronic 
scanning. For PAM, where a single laser pulse generates a 1D depth-resolved image, 2D 
raster scanning or arbitrary trajectory scanning of the ultrasonic transducer is employed to 
obtain a 3D image. For PACT with a 1D transducer array, where a single laser pulse 
generates a 2D cross-sectional image, orthogonal scanning along the elevational direction or 
rotational scanning around the object is needed to obtain a 3D image. For PACT with a 2D 
transducer array, a single laser shot can theoretically generate a 3D image 28; in practice, 
however, either electronic or mechanical scanning of the transducer array is needed to 
complete data acquisition.
MATCHING PAT SYSTEMS WITH APPLICATIONS
A given study may be best matched with a particular PAT system. The three typical 
questions concern (1) the imaging depth, (2) the imaging speed or temporal resolution, and 
(3) the imaging contrast. To best address a specific problem, one may need to optimally 
trade off the performance parameters of PAT. As a guide, Fig. 3 categorizes the major PAT 
implementations according to these three criteria—depth, speed, and contrast of interest.
Imaging depth
Photon propagation in soft tissue can be loosely classified into four regimes, which define 
the penetration limits of various high-resolution optical imaging modalities (Fig. 4a) 34. The 
spatial resolution of PAT scales with the imaging depth over a wide range from the 
(quasi)ballistic regime (typically ≤1 mm in tissue) to the diffusive regime (typically ≥10 mm 
in tissue), up to the dissipation limit (~10 cm in tissue) 35. Reducing the imaging depth of 
PAT improves its spatial resolution, approximately in proportion. As a rule of thumb, the 
ratio of the imaging depth to the resolution is ~200, permitting PAT to provide high-
resolution imaging across a wide range of imaging depths (Fig. 3).
Considering the prevalence of confocal microscopy and two-photon microscopy in the life 
sciences, we illustrate how they compare to PAM and PACT in terms of imaging depth (Fig. 
4b). The imaging depth of confocal microscopy is limited to 100–200 μm in biological 
tissue, because it relies on the miniscule number of ballistic photons that have survived the 
round-trip optical attenuation. Two-photon microscopy improves the imaging depth by using 
longer excitation wavelengths, which reduces optical attenuation and broadens optical 
focusing. Nevertheless, the low two-photon excitation efficiency and the overwhelming 
surface signal still limit the penetration to ~1.5 mm. Compared with two-photon microscopy, 
OR-PAM can achieve a similar, if not greater, imaging depth for two reasons: (1) the signal 
amplitude depends linearly instead of quadratically on the excitation light intensity, and the 
detection suffers negligible acoustic attenuation; (2) time-resolved acoustic detection 
effectively suppresses the interference of the surface signal. Nevertheless, OR-PAM still 
relies on (quasi)ballistic photons to provide optically-defined lateral resolution. If the spatial 
resolution is relaxed to tens of micrometers, which is achievable with high-frequency 
ultrasonic detection, AR-PAM can be used to break into the quasi-diffusive regime (e.g., a 
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penetration of ~5 mm at 50 MHz ultrasonic detection 36), where most photons have 
experienced many scattering events. With acoustically defined lateral resolution, both 
ballistic and scattered photons reaching the target contribute to the PA signal. The 
penetration of AR-PAM is largely limited by high-frequency acoustic attenuation, and can 
potentially be extended to at least 10 mm with proportionately relaxed resolutions 37. If the 
desired spatial resolution is further relaxed to hundreds of micrometers, which is attainable 
with low-frequency ultrasonic detection (e.g., 5 MHz), PACT can be used to reach the 
diffusive regime with penetration demonstrated up to 70 mm in living tissue 38. However, 
PACT is still limited by dissipation to less than ~10 cm in soft tissue, where the optical 
fluence—the photon energy received per unit area (J/cm2)—is substantially attenuated due 
to both absorption and scattering. When the optical scattering effect is compensated for by 
using wavefront engineering technologies 39, it may be possible to approach a sufficient 
penetration toward the absorption limit (~1 m) for whole-body human imaging (Fig. 4a).
Spatial resolution
Once a desired imaging depth is determined, one can estimate the achievable spatial 
resolution (Fig. 5a). For imaging in the (quasi)ballistic regime, OR-PAM is preferred, as it 
can resolve single cells or organelles (Fig. 5b–c). OR-PAM is useful for studying cancer 
angiogenesis, where neo-capillaries are less than 10 μm in diameter, and for single-cell 
flowmetry, where the functions of individual cells are of interest 40. AR-PAM is preferred 
for imaging in the quasidiffusive regime. An imaging depth of ~5 mm and tissue-level (~50 
μm lateral and 15 μm axial) spatial resolutions have been achieved (Fig. 5d) 12. For imaging 
in the diffusive regime—reaching the depths of whole-body small animals (Fig. 5e), PACT 
with spatial resolution of hundreds of micrometers is preferred (Fig. 5f) 31.
The spatial resolution of PAT can be tuned optically and acoustically (Fig. 5a). For OR-
PAM, a shorter excitation wavelength and tighter optical focusing yield finer lateral 
resolution, and a wider ultrasonic detection bandwidth in MHz provides better axial 
resolution. Nevertheless, it is worth noting that the axial resolution of OR-PAM with a tens 
of MHz detection bandwidth is on the level of tens of micrometers. The recent development 
of OR-PAM with an ultra-wide detection bandwidth (in GHz) has provided approximately 
isotropic resolutions 41. However, the strong acoustic attenuation at ultra-high ultrasound 
frequencies limits the applications to single-cell studies. For AR-PAM, a wider ultrasonic 
detection bandwidth similarly provides better axial resolution, while a higher central 
ultrasonic detection frequency benefits lateral resolution. Further, a tighter acoustic focusing 
improves lateral resolution at the cost of focal zone, which is defined as the depth range 
within which the lateral resolution degrades up to ~1.4 times. The spatial resolutions of 
PACT can be improved by increasing the central frequency and bandwidth of the ultrasonic 
transducer array. However, in all cases, spatial resolution is improved at the expense of 
penetration.
Super-resolution OR-PAM that beats the optical diffraction limit has recently been achieved. 
Various nonlinear mechanisms have been used to increase resolution, including optical 
absorption saturation (Fig. 5b) 42, photothermal nonlinearity 43, two-photon absorption 44, 
nano-bubble cavitation 45, thermal or Grueneisen relaxation 46, photothermal bleaching 47, 
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and reversible photoswitching 48. Just as in confocal microscopy and two-photon 
microscopy, in addition to the enhancement in lateral resolution, nonlinear OR-PAM 
automatically enables optical sectioning, which provides at least 10-fold finer axial 
resolution than the time-resolved acoustic sectioning in conventional linear OR-PAM.
Imaging speed
Biological functions occur on a wide variety of temporal scales. Various implementations of 
PAT offer a wide range of imaging speeds with associated tradeoffs (Fig. 3). Scientists 
should choose imaging systems with only the needed imaging speeds so that the other 
performance parameters can be optimized.
For OR-PAM (Fig. 2a–b), different scanning mechanisms can be employed according to the 
desired imaging speeds 49. Unlike confocal or two-photon microscopy, PAM does not 
require depth scanning for 3D imaging, due to its time-resolved acoustic detection. When 
video-rate 3D imaging is needed, the excitation laser beam can be raster-scanned within the 
acoustic focal spot (~50 μm in diameter), although this confines the field of view. A 3D 
imaging rate of ~30 Hz, limited largely by the laser pulse repetition rate, has been used to 
image single red blood cells flowing in capillaries. Random-access scanning over only the 
features of interest while skipping the background, enabled by a digital micromirror array, 
can further improve the imaging speed 50. Unfocused acoustic detection can enlarge the field 
of view—up to ~6 mm in diameter as demonstrated thus far—at the expense of signal 
amplitude 51. Recently, hybrid scanning, using a water-immersible MEMS mirror that 
confocally steers both the excitation laser beam and the emitted acoustic beam, has achieved 
a 3D imaging rate of ~1 Hz, with a moderate field of view of ~3 × 4 mm2 and 
uncompromised detection sensitivity 52, 53. If lower-dimensional imaging suffices, the 
imaging rate improves with each reduced dimension by approximately two orders of 
magnitude.
For AR-PAM (Fig. 2c), the imaging speed is mainly limited by the mechanical scanning 
speed and the pulse repetition rate of the higher pulse-energy laser, the latter of which is 
limited by safety of laser exposure on the tissue. In AR-PAM, mechanical scanning by a step 
motor or a voice-coil scanner is typically used with a scanning step size ~10 times that in 
OR-PAM. A 2D imaging rate of 40 Hz has been achieved by AR-PAM over a scanning 
range of ~9 mm, sufficient to capture the oxygenation dynamics in a mouse heart within a 
heart beat 36.
For PACT that provides a large field of view, the imaging speed is usually limited by the 
pulse repetition rate of the laser and the time required for multiplexed data acquisition. 
Using a 1D or 2D ultrasonic transducer array, a single laser shot can theoretically generate a 
2D or 3D image over the entire field of view. However, multiplexed data acquisition, which 
is usually adopted to reduce costs, slows down data collection. Commercially-available 
high-pulse-energy lasers used in PACT typically operate at a repetition rate less than 50 Hz. 
In addition, because repeated wide-field illumination may cause tissue damage due to 
accumulated heating, the average fluence rate (W/cm2) in addition to the fluence (J/cm2) per 
pulse on the tissue surface should be controlled to prevent damage 54. A recently developed 
PACT system with a hemispherical ultrasonic transducer array (256 elements) has achieved 
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a 3D imaging rate of ~50 Hz over a field of view of 15 × 15 × 7 mm3 (Fig. 2f), which is 
sufficient to image in real time the beating heart of a mouse and the neuronal activities of a 
swimming zebra fish 28. However, the sparse spatial sampling due to the limited number of 
transducer elements induces imaging artifacts outside the central field of view. For PACT 
systems based on a Fabry-Perot interferometer (Fig. 2g), the spatial resolutions can be well 
maintained with dense spatial sampling over the field of view, but the imaging speed is 
limited by the point-by-point scanning of the probing beam 30. Wide-field detection of the 
interference pattern, using time-gated light illumination and a high-speed CCD camera, can 
potentially speed up imaging 55, 56.
Imaging contrast and sensitivity
To study a given biological phenomenon, scientists also need to identify an optimal imaging 
contrast that can report the phenomenon with high sensitivity or specificity or both. Because 
PAT does not rely on fluorescence, any molecule can theoretically be imaged as PA contrast 
as long as nonradiative relaxation occurs. Both endogenous and exogenous contrast agents 
have been extensively explored by PAT 57, 58.
Endogenous contrast agents have several major advantages: (1) nontoxicity, (2) 
nonperturbation to biology, (3) abundance, and (4) freedom from regulatory approval. The 
most commonly imaged endogenous contrast agents in PAT include DNA/RNA 59, 
hemoglobin 31, melanin 40, lipids 36, and water 60 (Fig. 3). Among them, hemoglobin is 
most commonly used for label-free hemodynamic imaging, providing anatomic, functional 
and metabolic information about blood vessel diameter, total hemoglobin concentration, 
blood oxygenation, blood flow, and oxygen metabolism.
Exogenous contrast agents have two advantages over endogenous ones: (1) optimization for 
greater detection sensitivity and (2) conjugation with targeting molecules (e.g., antibodies) 
to selectively bind to receptors for molecular imaging. A wide range of exogenous contrast 
agents—including organic dyes 61, fluorescent proteins 62, non-fluorescent proteins 48, and 
nanoparticles 63—have been investigated for high-sensitivity PA molecular imaging (Fig. 3).
Quantitative spectroscopic PA imaging, where the tissue is sequentially illuminated at 
multiple wavelengths, has been commonly used to separate signals from multiple types of 
optical absorbers (Fig. 6a) 64. However, quantifying the absorber concentrations generally 
requires knowledge of the local optical fluence at different wavelengths, which is often 
difficult to estimate, especially in deep tissue, due to the strong but usually unknown 
wavelength-dependent light attenuation. Other factors, including PA signal generation 
efficiency, nonlinear optical absorption, and non-uniform light illumination and acoustic 
attenuation, also complicate the quantification. Recently, statistical unmixing methods using 
adaptive matched filters have demonstrated better performance than the conventional least-
squares-based methods, showing more robustness to the uncertainties of the background 
signals 65. However, these methods are more suitable for identifying sparsely distributed 
absorbers rather than quantifying their concentrations. For more detailed discussion, readers 
are referred to comprehensive reviews of inverse methods for quantitative spectroscopic PA 
imaging 64.
Wang and Yao Page 8
Nat Methods. Author manuscript; available in PMC 2016 August 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
To achieve high detection sensitivity at depths, contrast agents with large optical absorption 
cross-sections in the red or near-infrared (NIR) spectral region are usually preferred (Fig. 
6b) as detailed in the companion review 58. Due to their large particle sizes and/or the 
surface plasmon resonance effect, nanoparticles generally provide high sensitivity and thus 
have been widely studied for PAT 14, although they usually have long circulating times in the 
bloodstream and poor clearance from the body. Organic dyes are also widely used as PA 
contrast agents, due to their relatively short circulating times and fast clearance from the 
body 66. Genetically encodable proteins (fluorescent or not) have become increasingly 
popular in PA molecular imaging, due to their high selectivity and ease of exogenous 
delivery 15, 20, 62, 67–71. Novel methods using activatable nanoparticles or photoswitchable 
proteins have been reported (Fig. 6c) 48, 72, which can effectively enhance the detection 
sensitivity.
To further improve PA detection sensitivity, which is often quantified as the noise-equivalent 
detectable concentration of a contrast agent, one can maximize the target signal amplitude, 
suppress the background signal amplitude, optimize the electronics, and reduce the noise 
amplitude. Increasing the optical fluence and tuning the laser wavelength toward the 
absorption peak, in addition to choosing contrast agents with large optical absorption cross-
sections, increase the target signal amplitude, as long as the temperature rise per laser pulse 
is within the safety range. The American National Standards Institute (ANSI) has detailed 
standards for laser exposure to the skin and eye 54. Within the ANSI limit, PAT is safe for in 
vivo imaging, due to the adequate conversion efficiency from temperature rise to acoustic 
pressure (i.e., 1 mK temperature rise leads to a detectable ~800 Pa pressure rise). Also, 
matching the ultrasonic transducer with the detectable PA signal spectrum, which is 
primarily limited by the depth of the target, maximizes the detection efficiency. While the 
detection sensitivity of a conventional piezoelectric ultrasonic transducer degrades with 
decreasing element size, the sensitivity of optical sensors of acoustic waves, typically based 
on interferometry, does not. Therefore, optical detection holds great promise for high-
sensitivity PAE, where the ultrasonic transducer must be miniaturized. The electronics of 
PAT systems can be optimized by matching the impedances of the ultrasonic transducers and 
the amplifiers, in addition to picking low-noise amplifiers. The noise level can be reduced by 
shortening the cables, grounding the amplifiers, and shielding external interferences.
SELECTED APPLICATIONS
PAT has found broad applications in the life sciences, especially in functional brain 
mapping, cancer diagnosis, tissue engineering, developmental biology, and cell biology, as 
comprehensively reviewed elsewhere 19. Here, we sample only several representative 
application areas where PAT has played increasingly important roles. We also highlight two 
case studies in Table 1.
PAT has enabled functional and metabolic brain imaging at both microscopic and 
macroscopic scales, providing valuable information about brain vasculature 73, oxygenation 
(Fig. 7a) 27, metabolism of oxygen and glucose 74, resting state connectivity 75, and brain 
responses to various physiological and pathological challenges 76–78. PAT can provide 
neuronal imaging using either endogenous contrast from lipids or exogenous contrast from 
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dyes 79. In addition, PAT has been increasingly used to study small-animal models of brain 
diseases, including stroke 80, epilepsy 81, and edema 60. Recently, light-weight head-
mounted PACT systems have been developed, an important step towards functional PA 
imaging of brains in free-moving animals 82.
High-resolution imaging of single cells is crucial in cell biology. OR-PAM, with sub-
micrometer to micrometer resolution, is well suited for imaging single-cell morphology and 
function 83. For cell morphology, OR-PAM can perform in vivo histologic imaging without 
staining, by imaging DNA and RNA within the cell nuclei and cytochromes within the 
cytoplasm. Using ultrasonic transducers with extremely high frequencies (>1 GHz), OR-
PAM has revealed morphological abnormality of diseased red blood cells, and can 
differentiate white blood cell types according to the frequency features of their PA 
signals 41, 84, 85. For cell function, PA oxymetry is capable of label-free imaging of oxygen 
unloading in single red blood cells in vivo (Fig. 7b) 86. PA flowmetry can detect circulating 
tumor cells in the blood stream, with high sensitivity and high throughput, using endogenous 
contrast (e.g., melanin 40, 87) or targeted exogenous contrast (e.g., gold nanoparticles 
targeting breast cancer cells 18).
PAT has been widely used for cancer studies 88, including fundamental research in 
carcinogenesis89, cancer detection and staging63, and navigation and evaluation in cancer 
treatment 90. In particular, PAT is a perfect tool for label-free imaging of melanoma with 
melanin as the intrinsic contrast agent, because melanoma cells have orders of magnitude 
stronger optical absorption in the red and NIR spectral regions than red blood cells. OR-
PAM can resolve single melanosomes in melanoma cells 42, AR-PAM can monitor 
melanoma development in deep small-animal brains 91, and PACT has successfully imaged 
transgenic cancer cells expressing high-level melanin with a tyrosinase-based genetic 
reporter (Fig. 7c) 70. For cancers that are devoid of high-contrast intrinsic pigments, targeted 
nanoparticles or organic dyes can provide exogenous contrast by selectively binding to the 
surface receptors of cancer cells 13, 18, 88, 92–95. In addition to the tumor itself, 
microenvironmental cancer hallmarks can be imaged. Both high-resolution PAM and deep-
penetration PACT have provided label-free imaging of tumor angiogenesis and tumor 
hypoxia, two major cancer hallmarks 13, 96, 97. The abnormal metabolisms of oxygen and 
glucose in cancers, also major cancer hallmarks, have been investigated by using PAT with 
endogenous and exogenous contrasts, respectively 74, 96.
OUTLOOK
The strong momentum of PAT development is fueled by its increasingly popular applications 
in the life sciences and its commercialization for pre-clinical and clinical research. Several 
typical engineering challenges of PAT implementations and their solutions are summarized 
in Box 2.
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Box 2
Engineering challenges in PAT implementations
As discussed above, when implementing a PAT system for a particular life science study, 
the major components, such as the light source, ultrasonic detection system, and scanning 
system, should be chosen according to the required imaging performance. Several typical 
engineering challenges in PAT implementations deserve attention. For OR-PAM, the 
major engineering challenge is the confocal alignment of the focused optical excitation 
and acoustic detection. Different optical/acoustic beam combiners have been developed 
to achieve confocal alignment with a low numerical aperture (NA) optical focusing 
lens 49. Dark-field optical excitation and dark-field acoustic detection have also been 
used for confocal alignment 59. However, this challenge remains for reflection-mode OR-
PAM with a high NA (>0.6) optical focusing lens, which has a very limited working 
distance (<1 mm). A potential solution is to use a thin ultrasonic detector that is optically 
transparent, such as a micro-ring resonator 104. For AR-PAM, the major challenge is 
efficient light delivery to the deep acoustic focus without thermal damage to the skin 
surface. Weakly-focused dark-field optical excitation is so far the best solution, although 
the optimal excitation pattern is largely determined by the targeted imaging depth 105. For 
PACT, the major challenge is high-speed data acquisition with a multi-element ultrasonic 
transducer array. While multi-channel data acquisition systems (≥128 channels) are 
commercially available, they are expensive. A multi-channel acoustic waveguide with a 
single-channel signal detection system might be able to reduce the complexity and cost of 
PACT 106.
To tap the full potential of PAT, we face technological challenges—but none are beyond 
reach. (1) A single PAT system that fully integrates its multiscale imaging capability, with 
automatic image co-registration, would be invaluable. The major challenge is the seamless 
combination of optical illumination and acoustic detection required for different imaging 
depths of interest. An optically transparent ultrasonic transducer or transducer array may 
help simplify the system configuration. (2) Miniaturized PAT systems are of great interest 
for imaging freely-moving animals, especially for brain studies. The relatively low 
sensitivity of a miniaturized ultrasonic transducer and the limited options for fast acoustic 
scanning mechanisms are currently the major hurdles. High-speed wide-field optical 
detection of acoustic pressure might enable a solution. (3) Super-resolution PA methods with 
resolution finer than 50 nm are still needed to study subcellular structures that are either 
fluorescent or not, such as dendritic spines. The signal-to-noise ratio of the existing 
nonlinear PA methods is still insufficient to provide such high resolution at high speed. 
Donut-shaped illumination based methods, similar to the stimulated emission depletion 
(STED) microscopy, can potentially be adapted to improve the resolution. (4) Single-
molecule (fluorescent or not) detection by PAT is highly desirable for molecular cell biology. 
Novel ultrasonic detectors with high piezoelectric efficiency and low acoustic impedance 
need to be developed. (5) Absolute quantitative PA measurement of oxygenation and 
temperature in deep tissue remains a challenge, mainly due to the unknown local optical 
fluence, along with other secondary factors such as tissue-dependent PA generation 
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efficiency. New imaging methods and mathematical models are needed to better map the 
optical properties of the tissue. (6) Finally, for PAT of neuronal activities in the deep brain, 
novel genetically encodable indicators of action potentials or surrogates (e.g., voltage- or 
calcium-sensitive proteins), with large absorption cross-sections in the NIR spectral region, 
have to be found in nature or engineered from existing proteins. Along this line, non-
fluorescent NIR phytochromes (e.g., RpBphP) can be potentially engineered as PA imaging 
contrasts to report action potentials. The strong acoustic attenuation and aberration by the 
skull (especially the side skull) is another challenge for single-neuron PAT of the deep brain. 
A potential solution is to integrate PAT with X-ray CT, which provides data for accurate 3D 
modeling of the skull for acoustic correction.
In conclusion, with its rich optical absorption contrast and high ultrasonic scalability, PAT 
provides a comprehensive toolbox for the life sciences, complementing other imaging 
methods in its contrast mechanism, spatial-temporal resolution, and penetration. We expect 
PAT to find more high-impact applications in biomedical research.
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Figure 1. Principles of photoacoustic tomography (PAT)
(a) Jablonski diagram, illustrating the photon energy transfer in one-photon fluorescence 
microscopy, two-photon fluorescence microscopy, and PAT. The most common electronic 
absorption in the visible and ultraviolet spectral region is shown. (b) Imaging principle of 
PAT.
Wang and Yao Page 17
Nat Methods. Author manuscript; available in PMC 2016 August 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Representative implementations of PAT
(a) Transmission-mode OR-PAM system, where the ultrasonic transducer (UT) and the 
water-immersion focusing lens are on opposite sides of the object 98. Note that the focusing 
lens has a numerical aperture (NA) of 1.2 and a working distance of only ~200 μm. (b) 
Reflection-mode OR-PAM system with an optical-acoustic combiner that transmits light but 
reflects sound 96. SOL, silicone oil layer sandwiched between two prisms. (c) AR-PAM 
system with a dark-field illumination 12. The laser light is only weakly focused, with the UT 
in the dark cone. (d) PACT system with a ring-shaped ultrasonic transducer array (UTA) 99. 
The laser beam is expanded and homogenized by a diffuser to provide wide-field 
illumination. (e) PACT system with a linear UTA 100. The excitation light is delivered 
through a fused-end, bifurcated fiber bundle that flanks both sides of the UTA. (f) PACT 
system with a hemispherically shaped UTA 29. The UTA is rotated around the object to be 
imaged to provide dense spatial sampling for 3D imaging. (g) PACT system with a 2D 
Fabry-Perot interferometer as the acoustic sensor 70. The PA waves are recorded by raster 
scanning a probing laser beam over the surface of the interferometer. (h) Side-viewing 
intravascular PA catheter with an outer diameter of 1.25 mm, including the protective sheath 
in which the catheter rotates 23. Note that the acoustic coupling medium (typically water or 
ultrasound gel) is not shown in the schematics.
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Figure 3. Practical guide to mapping the desired imaging depth, speed and contrast to the 
optimal PAT implementation
For a specific biological problem, the most suitable category of PAT implementations 
depends primarily on the desired imaging depth. The representative reference for each PAT 
implementation is indicated in the square brackets.
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Figure 4. Photon propagation regimes in soft tissue and the penetration limits of representative 
high-resolution optical imaging modalities
(a) Photon propagation regimes in soft tissue and association with the penetration limits of 
high-resolution optical imaging modalities 34. The four regimes are divided approximately at 
photon propagation depths of 0.1 mm (aberration limit), 1 mm (diffusion limit), 10 cm 
(dissipation limit), and 1 m (absorption limit), with an optical absorption coefficient of 0.1 
cm−1, optical scattering coefficient of 100 cm−1 and anisotropy of 0.9. The classification 
holds in optical scattering dominant media. Note that the penetration limits shown here are 
order-of-magnitude approximations. (b) Signal generation and detection in confocal 
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microscopy (CFM), two-photon microscopy (TPM) and PAT, with different penetration 
limits in scattering tissue. The colors of the excitation light do not represent the true optical 
wavelengths.
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Figure 5. Multiscale PAT of single cells, whole-body small animals, and humans
(a) PAT implementations with approximate spatial resolutions and penetration limits suitable 
for structures ranging from organelles to whole-body small animals and humans. SR-PAM, 
super-resolution PAM. Note that the penetration limits and spatial resolutions shown here 
are order-of-magnitude approximations. (b) SR-PAM image of a single mitochondrion,42. 
Scale bar: 300 nm. (c) OR-PAM image of individual red blood cells 98. Scale bar: 7 μm. (d) 
In vivo AR-PAM image of subcutaneous vasculature of the palm of a human hand 12. Scale 
bar: 1 mm. (e) In vivo whole-body PACT image of a mouse, showing blood-rich internal 
organs 37. Scale bar: 5 mm. (f) In vivo PACT image of a human hand, showing its 
comprehensive vasculature. Image courtesy of Canon (Japan) (http://www.canon.com/
technology/future/index.html).
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Figure 6. In vivo PA molecular imaging
(a) PA images acquired at multiple wavelengths are combined with spectral unmixing 
algorithms to separate different types of optical absorbers 101. This example shows an NIR 
organic dye (shown in green) taken up by the kidneys in a mouse model, with the strong 
background signals from oxy-hemoglobin (HbO2, shown in red) and deoxy-hemoglobin 
(HbR, shown in blue). (b) Detection sensitivity of molecular probes. The detection 
sensitivities shown here are derived from reported results of representative contrast agents by 
adjusting them for both ANSI limited light fluences and 3 mm depth. (c) PACT image of a 
kidney tumor expressing reversibly switchable non-fluorescent bacterial phytochrome 
BphP1 48. The tumor is shown in color, and the background blood-rich organs are shown in 
gray. Scale bar: 1 mm.
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Figure 7. Representative in vivo PAT applications in life sciences
(a) Whole-cortex OR-PAM image of the oxygen saturation of hemoglobin in a mouse 
brain 53. The arteries (shown in red) and veins (shown in green) are clearly differentiated by 
their oxygenation levels. Scale bar: 1 mm. (b) Sequential label-free OR-PAM images of 
oxygen releasing in single red blood cells (RBCs) flowing in a capillary in a mouse brain 86. 
Scale bar: 10 μm. Blood flows from left to right. The dashed arrow follows the trajectory of 
a single flowing RBC. (c) PACT images of tyrosinase-expressing K562 tumor (shown in 
yellow) after subcutaneous injection into the flank of a nude mouse 70. The surrounding 
blood vessels are shown in gray. Top, x-y projection image; bottom, y-z projection image. 
Scale bar: 1 mm.
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Table 1
Major components and imaging parameters of sub-wavelength OR-PAM (SW-OR-PAM) and whole-body 
PACT (WB-PACT).
PAT SW-OR-PAM 98 WB-PACT 31
Optical excitation
Light source Nd:YVO4 laser Alexandrite laser
Pulse energy 10 nJ 100 mJ
Pulse width 1.5 ns 75 ns
Wavelength 532 nm 755 nm
Pulse repetition rate 16 kHz 10 Hz
Beam shape Tightly focused illumination (~220 nm in diameter) Wide-field illumination (~8 cm in diameter)
Ultrasonic detection
Transducer Single-element spherically focused transducer Concave arc-shaped array with 64 elements
Central frequency 40 MHz 3.1 MHz
Bandwidth 40 MHz 2.4 MHz
Scanning mechanism Raster scanning of the object to be imaged Rotational scanning of the object to be imaged
Data acquisition
Signal amplification 48 dB 70 dB
Channel count Single channel 64 channels
Sampling rate 1 GHz 40 MHz
Image formation Direct envelope extraction Back-projection reconstruction
Spatial resolution
Lateral 0.22 μm 0.5 mm
Axial 30 μm 0.5 mm
Imaging time (Field of view) ~1 min(100 × 100 × 100 μm3) ~8 min (4 × 4 × 6 cm3)
Penetration limit ~0.1 mm ~30 mm
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